Cognitive Rehabilitation Therapy for COVID-19
Part of paid clinical trials in San Diego, California.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT06086379
- Status
- Enrolling By Invitation
Conditions
- Post-Acute COVID-19 Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Compensatory Cognitive Training for COVID-19 — BEHAVIORALCCT-C is a manualized group-based behavioral intervention (10 weeks, 2 hours per week, 20 hours total) designed to improve cognition and everyday functioning in patients with prolonged COVID-19 symptoms
- Holistic Cognitive Education — BEHAVIORALHCE provides the same frequency and amount of therapist and other group member contact as CCT-C, but does not provide training in cognitive or lifestyle strategies addressed in CCT-C. The HCE intervention provides information and discussion regarding common causes of and treatments for cognitive impairment.
Study Details
Cognitive dysfunction, psychiatric symptoms, functional impairment, and disability following COVID-19 negatively impact Veterans' community functioning and quality of life, contribute to significant human suffering, and are costly to VHA. Rehabilitation is a critical priority for Veterans with long COVID. One promising treatment to improve functioning in Veterans with post-COVID-19 cognitive symptoms is Compensatory Cognitive Training (CCT). Previous studies have found that CCT is feasible, acceptable, and efficacious in Veteran populations with multiple sources of cognitive dysfunction. This randomized controlled trial aims to address important RR\&D priorities by examining feasibility, acceptability, and preliminary efficacy of a COVID-19-specific rehabilitation intervention, CCT for long COVID (CCT-C) compared to a robust control condition. The proposed study has the potential to improve cognitive function, functional independence, and quality of life for Veterans with late or delayed effects of secondary conditions related to COVID-19 infections.
Key Dates
- Start date
- Jul 1, 2024
- Status verified
- Jul 2025
- Primary completion
- Jun 30, 2026
- Completion
- Mar 31, 2029
Study Design
- Enrollment
- 70 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: CCT-C10-week Compensatory Cognitive Training Group
- Active Comparator: HCE10-week Holistic Cognitive Education Group
Primary Outcome Measure
Change in World Health Organization - Disability Assessment Schedule (WHODAS 2.0) [ Time Frame: baseline, 8 weeks ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| VA San Diego Healthcare System, San Diego, CA | San Diego | California | 92161-0002 | - |
Find similar trials in San Diego, CA
Related Studies
- Microbial and Cytokine Signatures in Long COVID PatientsEnrolling By Invitation · Palo Alto Medical Foundation · Palo Alto, California
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruiting · Brain Inflammation Collaborative · Delafield, Wisconsin
- Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia SyndromeRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Care for Veterans Post-COVID-19Recruiting · VA Office of Research and Development · East Orange, New Jersey